Valuation: 4DMedical Limited

Market Cap 1.97B 1.38B 1.21B 1.13B 1.03B 1.94B 132B 13.38B 5.23B 65.14B 5.16B 5.05B 225B P/E 2026 *
-10.3x
P/E 2027 * -52.3x
Enterprise Value 1.7B 1.19B 1.05B 974M 895M 1.68B 114B 11.58B 4.52B 56.38B 4.47B 4.37B 195B EV / Sales 2026 *
204x
EV / Sales 2027 * 78.1x
Free-Float
93.57%
Yield 2026 *
-
Yield 2027 * -
1 day+5.47%
1 week+2.50%
Current month-27.59%
1 month-21.15%
3 months-31.09%
6 months-19.01%
Current year-16.54%
1 week 3.06
Extreme 3.06
3.55
1 month 3.06
Extreme 3.06
4.69
Current year 2.95
Extreme 2.95
7.55
1 year 0.23
Extreme 0.23
7.55
3 years 0.22
Extreme 0.225
7.55
5 years 0.22
Extreme 0.225
7.55
10 years 0.22
Extreme 0.225
7.55
Manager TitleAgeSince
Chief Executive Officer - 01/12/2012
Director of Finance/CFO - 02/01/2026
Chief Tech/Sci/R&D Officer - 01/04/2023
Director TitleAgeSince
Director/Board Member - 01/12/2012
Chairman - 02/11/2023
Director/Board Member - 01/10/2017
Date Insider Type Main position Quantity % Market Cap.
19/06/26 Buy

Chief Financial Officer

11,363 0.0019%
19/06/26 Fiscal year

Chairman

-308,394 0.0518%
19/06/26 Fiscal year

Chairman

308,394 0.0518%
Change 5-day change 1-year change 3-year change Capi.($)
+5.47%+2.50%+1,212.00%+371.94% 1.3B
-1.54%+6.33%+15.38%-0.09% 211B
+2.61%-2.29%-3.17%-23.02% 135B
+5.73%+1.04%-27.76%+10.28% 119B
+2.85%+3.98%-57.00%-13.54% 65.77B
+0.50%-2.31%+5.80%+0.45% 47.58B
+1.43%+1.25%-25.87%-31.67% 44.44B
-0.49%+5.86%+15.35%+8.87% 39.14B
-0.93%+3.82%+22.77%+30.15% 36.79B
-2.38%+2.59%+72.43%-0.12% 29.37B
Average +1.36%+0.32%+122.99%+35.32% 72.94B
Weighted average by Cap. +1.36%+0.78%+0.05%-3.06%

Financials

2026 *2027 *
Net sales 8.34M 5.83M 5.13M 4.77M 4.38M 8.23M 559M 56.74M 22.16M 276M 21.9M 21.42M 955M 22.25M 15.56M 13.68M 12.74M 11.7M 21.96M 1.49B 151M 59.13M 737M 58.43M 57.17M 2.55B
Net income -177M -124M -109M -101M -93.06M -175M -11.87B -1.2B -470M -5.86B -465M -455M -20.27B -37.1M -25.95M -22.81M -21.23M -19.5M -36.61M -2.49B -252M -98.57M -1.23B -97.4M -95.3M -4.25B
Net Debt -264M -185M -163M -151M -139M -261M -17.74B -1.8B -703M -8.76B -694M -679M -30.27B -228M -160M -140M -131M -120M -225M -15.32B -1.55B -607M -7.56B -600M -587M -26.14B
Logo 4DMedical Limited
4DMedical Limited is a medical technology company that creates and deploys software-based cardiothoracic imaging technology integrating both algorithms and artificial intelligence. The Company's software platform delivers quantitative insights from routine clinical imaging to help clinicians assess lung function and cardiopulmonary disease. It provides thoracic imaging that enhances physician diagnoses and management of respiratory conditions. Its products include CT:VQ-Non-Contrast Ventilation-Perfusion, CAC-Coronary Artery Calcification, CT LVAS-Lung Ventilation Analysis, IQ-UIP-Early IPF Detection, LDAf-Functional Lung Density Analysis, LDAi-Lung Density Analysis – Inspiration, LTA-Lung Texture Analysis, PHA-Pulmonary Hypertension Assessment, XV LVAS-Lung Ventilation Analysis, and Companion Imaging. The CT:VQ is a non-contrast post-processing technology that transforms routine, chest computed tomographies (CTs) into quantitative, lobar ventilation (V) and perfusion (Q) maps.
Employees
124
Date Price Change Volume
27/07/26 A$3.280 +5.47% 3,541,741
24/07/26 A$3.110 -4.01% 4,898,873
23/07/26 A$3.240 -4.42% 2,878,126
22/07/26 A$3.390 -0.88% 3,424,502
21/07/26 A$3.420 -0.29% 4,772,716
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
3.280AUD
Average target price
4.967AUD
Spread / Average Target
+51.42%

Quarterly revenue - Rate of surprise